Literature DB >> 11723257

The genetic epidemiology of glioma.

R H Osborne1, M P Houben, C C Tijssen, J W Coebergh, C M van Duijn.   

Abstract

With traditional epidemiologic research designs, few environmental risk factors for malignant brain tumors have been revealed, and although syndromes exist where brain tumors occur frequently, these explain a small proportion of the overall incidence. In a similar way, the search for genetic causes has been thwarted by the rarity of families with multiple affected relatives, inhibiting genetic linkage, sib-pair, or even population-based association studies. Molecular genetic studies generally involve searching for candidate proto-oncogenes and tumor suppressor genes by comparing DNA from tumor material with constitutional (germline) DNA. However, it remains difficult to distinguish causative genetic aberrations from chaotic neoplastic processes, and studies so far have not yielded consistent information on the location of such causative genetic lesions. The current literature covering the molecular genetics of glioma is discussed herein and alternative approaches that can be used to identify genetic causes of glioma described.

Entities:  

Mesh:

Year:  2001        PMID: 11723257     DOI: 10.1212/wnl.57.10.1751

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

1.  Description of selected characteristics of familial glioma patients - results from the Gliogene Consortium.

Authors:  Siegal Sadetzki; Revital Bruchim; Bernice Oberman; Georgina N Armstrong; Ching C Lau; Elizabeth B Claus; Jill S Barnholtz-Sloan; Dora Il'yasova; Joellen Schildkraut; Christoffer Johansen; Richard S Houlston; Sanjay Shete; Christopher I Amos; Jonine L Bernstein; Sara H Olson; Robert B Jenkins; Daniel Lachance; Nicholas A Vick; Ryan Merrell; Margaret Wrensch; Faith G Davis; Bridget J McCarthy; Rose Lai; Beatrice S Melin; Melissa L Bondy
Journal:  Eur J Cancer       Date:  2013-01-04       Impact factor: 9.162

2.  MicroRNA-181 inhibits the proliferation, drug sensitivity and invasion of human glioma cells by targeting Selenoprotein K (SELK).

Authors:  Chun-Hua Xu; Li-Min Xiao; Er-Ming Zeng; Li-Ke Chen; Su-Yue Zheng; Dong-Hai Li; Yue Liu
Journal:  Am J Transl Res       Date:  2019-10-15       Impact factor: 4.060

3.  Human leukocyte antigen distribution analysis in North Italian brain Glioma patients: an association with HLA-DRB1*14.

Authors:  Franca R Guerini; Cristina Agliardi; Milena Zanzottera; Serena Delbue; Elisabetta Pagani; Carmine Tinelli; Renzo Boldorini; Pier Giorgio Car; Claudia Veggiani; Pasquale Ferrante
Journal:  J Neurooncol       Date:  2005-11-29       Impact factor: 4.130

4.  Knockdown of Gli1 by small-interfering RNA enhances the effects of BCNU on the proliferation and apoptosis of glioma U251 cells.

Authors:  Wenjia Guo; Hailong Tian; Xiaogang Dong; Jinping Bai; Xinling Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

5.  Associations between polymorphisms in DNA repair genes and glioblastoma.

Authors:  Roberta McKean-Cowdin; Jill Barnholtz-Sloan; Peter D Inskip; Avima M Ruder; Maryann Butler; Preetha Rajaraman; Pedram Razavi; Joe Patoka; John K Wiencke; Melissa L Bondy; Margaret Wrensch
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-24       Impact factor: 4.254

6.  Correlation between X-ray cross-complementing group 1 polymorphisms and the onset risk of glioma: A meta-analysis.

Authors:  Xinquan Gu; Hongyan Sun; Liping Chang; Ran Sun; Hongfeng Yang; Xuewen Zhang; Xianling Cong
Journal:  Neural Regen Res       Date:  2013-09-15       Impact factor: 5.135

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.